Bioequivalence: Issues and Options

By Midha Kamal K.   Rawson Maureen J.   Hubbard John W.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 6, 1997-12 ,pp. : 743-752

Springer Publishing Company

Access to resources Recommend Favorite

Bioequivalence of Levothyroxine Tablets Administered to a Target Population in Steady State

By Cerutti R.   Rivolta G.   Cavalieri L.   Di Giulio C.   Grossi E.   Vago T.   Baldi G.   Righini V.   Marzo A.  

Pharmacological Research, Vol. 39, Iss. 3, 1999-01 ,pp. : 193-201

Academic Press

Access to resources Recommend Favorite

Current regulatory approaches of bioequivalence testing

By Karalis Vangelis   Macheras Panos  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 8, 2012-08 ,pp. : 929-942

Informa Healthcare

Access to resources Recommend Favorite

Health-Related Quality of Life and Regulatory Issues in the US and Canada

By Glennie J.L.  

PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. : 371-377

Adis International

Access to resources Recommend Favorite

Health-Related Quality of Life (HR-QOL) and Regulatory Issues: An Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval

By Apolone G.  

PharmacoEconomics, Vol. 19, Iss. 2, 2001-01 ,pp. : 187-195

Adis International

Access to resources Recommend Favorite